[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ascending-aorta-abnormality\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ascending-aorta-abnormality":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100420397",false,"NCT04754217","Valved Graft PMCF Study","Valved Graft Post-Market Clinical Follow-up Study","Inclusion Criteria:\n\n* cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement\n\nExclusion Criteria:\n\n* anticoagulation therapy intolerant\n* active endocarditis\n* anatomical or medical, surgical, psychological or social contraindications","ALL","18 Years",{"count":18,"type":19},260,"ESTIMATED","OBSERVATIONAL","Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.",[23,24,25],"Aortic Valve Disease","Ascending Aorta Abnormality","Aortic Dissection",[27,28,29,30,31],"Aortic Root Replacement","Ascending Aorta Replacement","Valved Graft","CAVGJ","VAVGJ","RECRUITING","2026-04-07",{"date":35,"type":36},"2026-04-13","ACTUAL",{"date":38,"type":36},"2021-07-13",{"date":40,"type":19},"2029-09",{"name":42,"class":43},"Abbott Medical Devices","INDUSTRY",25,""]